SLV310, a molecule combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition

被引：0
|
作者：
Kruse, CG [1 ]
Tuinstra, T [1 ]
Herremans, A [1 ]
van Vliet, B [1 ]
Long, SK [1 ]
van der Heijden, JA [1 ]
Hesselink, MB [1 ]
机构：
[1] Solvay Pharmaceut, Res Labs, Weesp, Netherlands
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80853-8
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [21] Effects of pardoprunox (SLV308), a partial D2/D3 receptor and 5-HT1A receptor agonist, on rat dopamine and serotonin neuronal activity
    Betry, C.
    Etievant, A.
    Lambas-Senas, L.
    McCreary, A.
    Haddjeri, N.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S117 - S117
  • [22] Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations
    Ringel, Lauren E.
    Basken, Jaime N.
    Grant, Laura M.
    Ciucci, Michelle R.
    BEHAVIOURAL BRAIN RESEARCH, 2013, 252 : 252 - 259
  • [23] Dopamine D1 and D2 receptor agonism enhances antinociception mediated by the serotonin and noradrenaline reuptake inhibitor duloxetine in the rat formalin test
    Munro, Gordon
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 575 (1-3) : 66 - 74
  • [24] Dopamine D2/3 receptor antagonism reduces activity-based anorexia
    S J Klenotich
    E V Ho
    M S McMurray
    C H Server
    S C Dulawa
    Translational Psychiatry, 2015, 5 : e613 - e613
  • [25] Dopamine D2/3 receptor antagonism reduces activity-based anorexia
    Klenotich, S. J.
    Ho, E. V.
    McMurray, M. S.
    Server, C. H.
    Dulawa, S. C.
    TRANSLATIONAL PSYCHIATRY, 2015, 5 : e613 - e613
  • [26] Differential Modulation of Reinforcement Learning by D2 Dopamine and NMDA Glutamate Receptor Antagonism
    Jocham, Gerhard
    Klein, Tilmann A.
    Ullsperger, Markus
    JOURNAL OF NEUROSCIENCE, 2014, 34 (39): : 13151 - 13162
  • [27] Mutational and biochemical analysis of dopamine in dystoniaEvidence for decreased dopamine D2 receptor inhibition
    Richard D. Todd
    Joel S. Perlmutter
    Molecular Neurobiology, 1998, 16 : 135 - 147
  • [28] Novel, highly potent and selective serotonin 5-HT2A/dopamine D2 receptor antagonists as potential antipsychotics.
    Lee, TK
    Robichaud, AJ
    Boyle, KE
    Lu, YM
    Chen, WT
    McClung, C
    Deng, W
    Miller, KJ
    McElroy, JF
    Largent, BL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U17 - U17
  • [29] SLV318, a novel agonist for the dopamine D2 and D3 receptor:: In vitro and in vivo neurochenical characterization
    Hesselink, MB
    van der Neut, M
    Adolfs, T
    Feenstra, R
    Long, S
    van Scharrenburg, G
    MOVEMENT DISORDERS, 2002, 17 : S65 - S65
  • [30] In Vivo Effects of Pardoprunox (SLV308), a Partial D2/D3 Receptor and 5-HT1A Receptor Agonist, on Rat Dopamine and Serotonin Neuronal Activity
    Betry, Cecile
    Etievant, Adeline
    Lambas-Senas, Laura
    Mccreary, Andrew C.
    Haddjeri, Nasser
    SYNAPSE, 2011, 65 (10) : 1042 - 1051
12345